The scoreboard, honestly: the hard targets, how often each one is actually looked at,
and the quiet human signals that never make it onto a dashboard.
Strategic Alignment of Portfolio
Percentage of R&D spend allocated to projects directly supporting the top 3 corporate strategic goals.
Target · >90%If our top goals are 'Sustainable Materials', 'AI-driven Diagnostics', and 'Personalised Health', we'd expect over 90% of your managed portfolio's budget to clearly link to one of these areas. If you're spending £1M on a project that doesn't fit, we'll need to talk.
Innovation Rate Contribution
Contribution to increasing the percentage of company revenue derived from new products (launched within the last 3 years) within your managed research area.
Target · Increase by 2-5% annually (relative to baseline)If your research area is responsible for £10M in revenue, and 20% of that comes from new products, we'd expect to see that climb to 22-25% next year, demonstrating that your projects are successfully translating into market-ready innovations.
R&D Portfolio ROI
Achieving a portfolio-wide Return on Investment (ROI) for your managed research area that exceeds the industry benchmark by a specified factor.
Target · 1.5x industry benchmark ROIIf the industry average ROI for R&D in our sector is 10%, we'd be looking for your portfolio to deliver at least 15% ROI. This isn't just about individual project success; it's about smart capital allocation across the whole programme.
Major Milestone Adherence
Percentage of critical 'Go/No-Go' decisions and TRL advancements met on time and within budget for your major programmes.
Target · >85%If you have 10 major programmes under your wing, and 20 critical milestones planned for the quarter, we'd expect at least 17 of those to hit their targets without significant delays or cost overruns. We know R&D is unpredictable, but strategic planning matters.
Budget & Resource Optimisation
Managing your assigned P&L (£500K-£2M) with a variance of less than 5%, ensuring optimal allocation of financial and human resources across projects.
Target · <5% variance (positive or negative)If your annual budget is £1.5M, we're looking for you to spend between £1.425M and £1.575M, demonstrating tight control and smart reallocation when needed. It's not just about underspending; it's about efficient spending.
Team & Talent Development
Successfully developing and mentoring your team of managers and senior individual contributors, fostering a culture of high performance and continuous learning.
- Evidence includes observable growth in your direct reports (e.g., promotions, increased scope, successful project leadership), positive feedback in 360-degree reviews, and a clear talent pipeline for critical roles. We'll also look for your active involvement in succession planning and skill-building initiatives.
External Reputation & Influence
Representing the organisation effectively in external forums, building strategic partnerships, and influencing industry direction in your domain.
- This looks like being invited to speak at key industry conferences, leading working groups in consortia, securing new academic collaborations, or having your team's work cited in significant publications. It's about being seen as a thought leader, not just a participant.
Strategic Risk Management
Proactively identifying and mitigating strategic risks within your R&D portfolio, including technical, market, and intellectual property risks.
- We'll see this in your robust risk registers, clear mitigation plans for high-impact risks, and your ability to make tough 'kill' decisions early when the data points to insurmountable challenges. It's about preventing major failures, not just reacting to them. For example, spotting a potential FTO issue early and pivoting a project before significant investment.
Cross-Functional Collaboration & Buy-in
Building strong relationships and securing buy-in from commercial, product, and finance teams for your R&D initiatives, ensuring alignment from lab to market.
- This means commercial teams are actively pulling your innovations into their roadmaps, product teams are excited to build on your research, and finance understands the long-term value of your investments. It's about being a trusted partner, not just a 'science silo'. You'll be regularly invited to their strategic planning sessions.